Navigation Links
Press Statement Issued by Ranbaxy Laboratories Limited
Date:2/25/2009

GURGAON, India, Feb. 25 /PRNewswire/ -- Ranbaxy has just received a letter and information indicating that all pending and approved ANDAs from Ranbaxy's Paonta Sahib facility have been added to a list maintained under a policy entitled "Application Integrity Policy" or "AIP". Ranbaxy will analyze the letter and other information fully and respond appropriately in a timely manner.

The FDA has said it has no evidence the drugs on the market are substandard and also that they comply with specifications upon testing.

No products from Ranbaxy's other manufacturing facilities are included in the AIP.

Ranbaxy will continue to co-operate with the USFDA. Further, no effort or action will be spared to timely protect key ANDAs from Paonta Sahib, which include some First to File applications.

Ranbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy's continued focus on R&D has resulted in several approvals in developed markets and significant progress in New Drug Discovery Research. The Company's foray into Novel Drug Delivery Systems has led to proprietary "platform technologies," resulting in a number of products under development. The Company is serving its customers in over 125 countries and has an expanding international portfolio of affiliates, joint ventures and alliances, ground operations in 49 countries and manufacturing operations in 11 countries.

    Company Contacts for Media:

    India Contacts:

    Ramesh L. Adige
    President - Corporate Affairs and Global Corporate Communications
    Ranbaxy Laboratories Ltd.
    Plot 90, Sector 32, Gurgaon
    Haryana122001, India
    Tel: +91-124-4135000
    e-mail: '/>"/>
SOURCE Ranbaxy Laboratories Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
2. Children of depressed moms do better when dad is involved, SLU researcher finds
3. Clinical depression linked to abnormal emotional brain circuits
4. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
5. Specific antagonism lowers blood pressure
6. Are too many people diagnosed as depressed?
7. Depression Taking Toll on Returning U.S. Vets
8. Doctors Often Miss High Blood Pressure in Kids
9. Pill box organizers increase HIV patients adherence and improve viral suppression
10. Damp, Moldy Homes May Cause Depression
11. Treating depression may improve recovery of heart rate variability following coronary syndromes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)--In Youngest Babies, This Type of Blood Cancer Is Most Challenging-- ,, PHILADELPHIA and NEW ORLEANS, Dec. 5 Pediatric oncologists have identified specific genes, dubbed partner genes, that fuse w
(Date:12/5/2009)Research debunks the ,something,s wrong with being single, myth , , SATURDAY, Dec. 5 (HealthDay News) -- Pity the poor single people who pass their 40th birthday without ever tying the knot, s
(Date:12/5/2009)The MAMA campaign is a collaborative effort by the National Association of Certified Professional Midwives (NACPM), Midwives Alliance of North America (MANA), Citizens for Midwifery (CfM), Internation
(Date:12/4/2009)NEW YORK, Dec. 4 Care Investment Trust Inc. (NYSE: CRE ) ("Care" or the "Company") today announced that its Board of Directors has declared a dividend of $0.17 per share of common stock. The div
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
Breaking Medicine News(10 mins):Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 2Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 4Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2
...s today filed an appeal in their challenge of a co...eld by the Wisconsin Alumni Research,Foundation (W... for Taxpayer and Consumer,Rights, and the Public ...s requested a re-examination of the patent,in July...
...nnipeg (July 18, 2008) Funding of $4.4 million fr...R) was announced today by Steven Fletcher, MP for ... Secretary for Health, on behalf of Tony Clement, ...Health Commission of Canada is contributing $250,0...
...chigan State University scholar refutes commonly h..., more emotionally unstable and harder to get alon...ith the findings, employers are urged to guard aga...ent, and two colleagues studied the relationship b...
...paign to raise awareness, of the importance of t... compliance rates across the United St...ation, a,nonprofit organization dedicated to healt...ay, July 19 in conjunction,with the Ebenezer Afric...
...eld,United Concordia Companies, Inc. and Catholic ...es and lifestyles for Pittsburghers. Beginning at ...y 19, a free clinic will,offer health information ...re than other aspects of health care. The percepti...
...t old drug offers new hope , , FRIDAY, Jul...ne step back in the search for treatments against ...e July 19 issue of The Lancet , an older drug cal...er,s -- even though it cleared dementia-linked amy...
Other Medicine News:Health News:Consumer Groups File Appeal on Challenge of Human Stem Cell Patent Held By WARF 2Health News:CIHR announces $4.4 million to improve mental health of Canadians 2Health News:Studies refute common stereotypes about obese workers 2Health News:The COSHAR Foundation Participates in Annual Women's Health Awareness Day 2Health News:The COSHAR Foundation Participates in Annual Women's Health Awareness Day 3Health News:Highmark Blue Cross Blue Shield, United Concordia and Catholic Charities Join Forces to Offer Free Health, Dental Services This Saturday 2Health News:Alzheimer's Research Brings Progress, Setbacks 2Health News:Alzheimer's Research Brings Progress, Setbacks 3Health News:Alzheimer's Research Brings Progress, Setbacks 4
(Date:12/4/2009)SALT LAKE CITY, Dec. 4 Dynatronics Corporation (Nasdaq: DYNT ) announced it has signed a sole-source vendor agreement to provide therapy equipment and rehab supplies to Benchmark Physical Therapy wi
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today the presentation of new d
(Date:12/4/2009)LAKE FOREST, Ill., Dec. 4 Hospira, Inc. (NYSE: HSP ), a leading global specialty pharmaceutical and medication delivery company, today announced the launch of its next-generation 50 mL and 100 mL V
Breaking Medicine Technology:PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 1ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 2ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 3ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 4ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 5EUCODIS Bioscience Launches Beta Lactamase for Antibiotics and Diagnostics Industries 12462 1EUCODIS Bioscience Launches Beta Lactamase for Antibiotics and Diagnostics Industries 12462 2Cardiac Science to Present at Needham Biotechnology 26 Medical Technology Conference 47874 1Cardiac Science to Present at Needham Biotechnology 26 Medical Technology Conference 47874 2Cardiac Science to Present at Needham Biotechnology 26 Medical Technology Conference 47874 3
49 Pinhole short handle
Frosted Long Handle Occluder
LM-380
LM 15C
Medicine Products: